NCT04522336 2026-03-05
Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
Clinical Trials
1 trialsActive not recruiting × Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 × 90 days × Clear all